Hunter, Rachael

Randomised feasibility study of physiotherapy for patients with functional motor symptoms

Nielsen, G., Buszewicz, M., Stevenson, F., Hunter, R., Holt, K., Dudziec, M., Ricciardi, L., Marsden, J., Joyce, E., & Edwards, M. (2017) · Journal of Neurology, Neurosurgery & Psychiatry

Psychosomatic Disorders and Their TreatmentsFibromyalgia and Chronic Fatigue Syndrome Research

Cited by 246

Maintenance or Discontinuation of Antidepressants in Primary Care

Lewis, G., Marston, L., Duffy, L., Freemantle, N., Gilbody, S., Hunter, R., Kendrick, T., Kessler, D., Mangin, D., King, M., et al. (2021) · New England Journal of Medicine

Treatment of Major DepressionMental Health Treatment and Access

Cited by 192

Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson’s disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The ‘Exenatide-PD3’ study

Vijiaratnam, N., Girges, C., Auld, G., Chau, M., Maclagan, K., King, A., Skene, S., Chowdhury, K., Hibbert, S., Morris, H., et al. (2021) · BMJ Open

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 84

Clinical and cost-effectiveness of the managing agitation and raising quality of life (MARQUE) intervention for agitation in people with dementia in care homes: a single-blind, cluster-randomised controlled trial

Livingston, G., Barber, J., Marston, L., Stringer, A., Panca, M., Hunter, R., Cooper, C., Laybourne, A., La Frenais, F., Reeves, S., et al. (2019) · The Lancet Psychiatry

Dementia and Cognitive Impairment ResearchGeriatric Care and Nursing Homes

Cited by 62

Healthcare resource utilisation and costs of agitation in people with dementia living in care homes in England - the managing agitation and raising quality of life in dementia (MARQUE) study

Panca, M., Livingston, G., Barber, J., Cooper, C., La Frenais, F., Marston, L., Cousins, S., & Hunter, R. M. (2019) · PLOS ONE

Dementia and Cognitive Impairment ResearchGeriatric Care and Nursing Homes

Cited by 29

A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial

Duffy, L., Bacon, F., Clarke, C. S., Donkor, Y., Freemantle, N., Gilbody, S., Hunter, R., Kendrick, T., Kessler, D., King, M., et al. (2019) · Trials

Treatment of Major DepressionMental Health Treatment and Access

Cited by 22